ct

Patent Pick: 'Shocking' Skin Delivery News

April 18, 2016 | Contact Author | By: Rachel L. Grabenhofer, Cosmetics & Toiletries
Close
Fill out my online form.
  • Article
  • Keywords/Abstract
Lightning-storm-850

Keywords: delivery | skin care | The Estee Lauder Companies | iontophoresis | microcurrent | patch | mask

Abstract: This Estée Lauder Companies patent describes a system to deliver skin care agents into the skin via a patch or mask that generates microcurrent.

The Estée Lauder Companies has developed a system to deliver skin care ingredients to multiple targeted areas for different concerns. Described in the following patent application, the skin care agents penetrate the skin via a patch or mask that generates microcurrent. 

Targeted delivery of skin care treatments with microcurrent in a mask or patch form
WIPO Patent Application WO/2016/053687 
Publication date: April 7, 2016 
Assignee: The Estée Lauder Companies Management, LLC 

Excerpt Only This is a shortened version or summary of the article you requested. To view the complete article, please log in or create an account. Registration is Free!

The Estée Lauder Companies has developed a system to deliver skin care ingredients to multiple targeted areas for different concerns. Described in the following patent application, the skin care agents penetrate the skin via a patch or mask that generates microcurrent. 

Targeted delivery of skin care treatments with microcurrent in a mask or patch form
WIPO Patent Application WO/2016/053687 
Publication date: April 7, 2016 
Assignee: The Estée Lauder Companies Management, LLC 

Described in this patent application is a facial treatment delivery system. It uses skin care benefit agents and iontophoresis in micro-current zones to treat multiple targeted areas of concern. The system includes a sheet substrate with said skin care agents and a reduction agent, in addition to a separate activating cream with an oxidation agent.

The activating cream is applied to the skin, followed by the sheet substrate. The combined reduction agent of the sheet substrate and the oxidation agent of the activating cream cause a redox reaction to generate microcurrent. This current facilitates the delivery of skin benefit agents from the sheet by iontophoresis, or can directly affect other treatments by delivering iontophoresis microcurrent to the skin.